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Conclusion: Community acquired meningitis by an organism of en-
teric flora in an immunocompromised patient should raise the sus-
picion of hyperinfection syndrome in endemic areas. Since eradi-
cation of parasite may be delayed, repeated stool examination and
prolonged treatment are required.
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Background: In patients with HIV/AIDS uncontrolled Epstein Barr
Virus (EBV) replication produces high viral loads that expand the
pool of latently infected cells vulnerable to development of B-
lineage tumors: non-Hodgkins lymphoma (NHL) and classic Hodgkin
lymphoma (HL). HAART accompanied by T-cell reconstitution dra-
matically reduced the incidence of EBV+ lymphomas, with the sur-
prising exception of HL. Though EBV+ HL, can be distinguished from
NHL by several criteria, a major difference is the grossly aneu-
ploid nature of the malignant RS cell, a post-germinal center B-cell
characterized by aberrant centrosomes and grossly abnormal chro-
mosomes. Although latent cycle products alone were believed to
promote viral tumorigenesis, accumulating evidence suggests lytic
cycle proteins also play a critical role. The lytic enzyme EBV thymi-
dine kinase (TK) is a modest dT kinase with a large N-terminus of
unknown function. It is present in the virion tegument and interacts
with multiple viral and cellular proteins forming a dominant node
in the viral interactome. How and why these diverse interactions
regulate virion production is entirely unknown. We recently found
that unique among herpesvirus proteins, EBVTK strictly localizes to
centrosomes. Significantly, upon lytic induction EBVTK is detected
in centrosomes containing structural and numerical abnormalities.
The centrosome is the master regulator of the microtubular cy-
toskeleton and controls the physical work of cell division. Minor
perturbations of centrosome content cause errors in chromosome
segregation, cytokinesis and cell cycle regulation, promoting ane-
uploidy and tumorigenesis.
Objective: To uncover the role(s) of EBVTK in control of lytic in-
fection and in development of centrosome abnormalities.
Methods: Biochemical characterization of native enzyme. Con-
struction and expression of wild type TK and a series of TK mu-
tants followed by microscopy to detect localization and pertur-
bation of centrosome/microtubule function in different cell types
(yeast-human).
Results: EBVTK is a phosphoprotein in eukaryotic cells; phosphory-
lation plays distinct roles in different enzyme functions.
Conclusions: EBVTK is a multifunctional protein that performs dis-
tinct roles during different stages of the virus life cycle. TK ex-
pression may predispose to centrosome abnormalities resulting in
aneuploidy as seen in EBV+ HL.
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Background: Zygomycosis is a life-threatening invasive fungal
infection most prevalent among immunocompromised patients.
Posaconazole (POS) is a novel antifungal triazole with activity
against zygomycetes. Granulocyte colony-stimulating factor (G-
CSF) is known to augment neutrophil activity, in vitro, and improve
the effects of antifungal drugs.
Objective: The aim of this study was to develop a neutropenic
murine model of disseminated zygomycosis and evaluate the effi-
cacy of POS alone or in combination with G-CSF.
Methods: Male Balb-c mice were infected via the lateral tail vein
with 5×104 conidia R. microsporus/mL. At 24 hour post-infection
the mice were divided in four groups of five. Each group was
treated with POS (40 mg/kg/day by gavage), or G-CSF (300 mi-
cro g/kg/day subcutaneously), or with the combination of POS+G-
CSF. In the control group, animals were treated with saline. Mice
were rendered neutropenic with cyclophosphamide (200 mg/kg,
intraperitoneally) administered on days –1 and +5. Mortality was
recorded for 10 days and survival was assessed with Kaplan-Meier
curves. The fungal burden of the brain, liver, kidneys and lungs
was evaluated with semi-quantitative cultures and statistical anal-
ysis was performed using arbitrary score units (n`mice).
Results: The mean survival times were 6.56±0.57 days for the con-
trols, 7.53±0.51 days for POS-treated mice (P=0.098 vs controls),
6.93±0.56 days for G-CSF-treated mice (P=NS) and 7.13±0.59
days for POS+G-CSF-treated mice (P=NS). Combination therapy
(P=0.022) as well as POS monotherapy (P=0.037) reduced signifi-
cantly the fungal burden in the kidneys. The reduction of fungal
burden in the rest of the organs was not statistically significant.
Conclusions: Posaconazole monotherapy and POS+G-CSF combina-
tion therapy had a modest efficacy against R. microsporus. Fur-
thermore, POS and combination therapy reduced significantly the
fungal burden in the kidneys, while a moderate reduction of fungal
burden was observed for the rest of the organs. Combining G-CSF
with POS did not substantially affect the antifungal efficacy of POS.
120
(1→3)-β-D-Glucan in Cereobrospinal Fluid is a Surrogate
Marker for Detection and Therapeutic Response of
Hematogenous Candida Meningoencephalitis
Ruta Petraitiene1,2, Vidmantas Petraitis1,2, William Hope1,
Diana Mickiene1,2, Amy Kelaher1, Heidi Murray1,
Christine Mya-San1, Johanna Hughes1, Margaret Cotton1,
John Bacher3, Danny Bemjamin4, Thomas Walsh1.
1Immunocompromised Host Section, Pediatric Oncology Branch,
National Cancer Institute, Bethesda, USA; 2Laboratory Animal
Sciences Program, SAIC-Frederick, Inc., Frederick, USA; 3Surgery
Service, Veterinary Resources Program, Office of Research
Services, Bethesda, MD, Duke University, Durham, USA
Background: Hematogenous Candida meningoencephalitis (HCME)
is a common complication of candidemia in immunocompromised
pediatric patients, particularly neonates, resulting in abscesses,
seizures, ventricular hemorrhage, mental retardation, and death.
CSF cultures are often negative and early diagnosis of HCME is dif-
ficult.
Objectives: To characterize the potential diagnostic utility of CSF
(1→3)-β-D-glucan as a biomarker for the detection and therapeutic
monitoring of HCME.
Methods: The kinetics of expression of (1→3)-β-D-glucan in blood
and CSF was studied in a well-established non-neutropenic rab-
bit model of HCME caused by Candida albicans. Levels of (1→3)-
β-D-glucan were measured by factor G Limulus assay (Cape Cod
Associates). Micafungin (MICA) (0.5 to 32 mg/kg/d IV) and deoxy-
cholate amphotericin B (DAmB) (1 mg/kg/d IV) were administered
to study the effects on expression of (1→3)-β-D-glucan for thera-
peutic monitoring.
Results: Among untreated controls (UC) (n=25), C. albicans es-
